(Q30328006)

18 June 2017

The human cell line PER.C6 provides a new manufacturing system for the production of influenza vaccines. (English)

1 reference

18 June 2017

0 references

Pau MG

1

1 reference

18 June 2017

Ophorst C

2

1 reference

18 June 2017

Koldijk MH

3

1 reference

18 June 2017

Schouten G

4

1 reference

18 June 2017

Mehtali M

5

1 reference

18 June 2017

Uytdehaag F

6

1 reference

18 June 2017

language of work or name

English

0 references

publication date

1 March 2001

1 reference

18 June 2017

6

1 reference

inferred from page(s)

published in

Vaccine

1 reference

18 June 2017

19

1 reference

18 June 2017

2716-2721

1 reference

18 June 2017

17-19

1 reference

describes a project that uses

18 June 2017

PER.C6

0 references

cites work

New helper cells and matched early region 1-deleted adenovirus vectors prevent generation of replication-competent adenoviruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900508-9

7 January 2021

Effects of egg-adaptation on the receptor-binding properties of human influenza A and B viruses

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900508-9

7 January 2021

Characterization of high-growth reassortant influenza A viruses generated in MDCK cells cultured in serum-free medium

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900508-9

7 January 2021

Selection of receptor-binding variants of human influenza A and B viruses in baby hamster kidney cells

1 reference

https://api.crossref.org/works/10.1016%2FS0264-410X%2800%2900508-9

7 January 2021

10.1016/S0264-410X(00)00508-9

Identifiers

DOI

1 reference

18 June 2017

1 reference